Guide for Authors
The goal of
Genomics is to promote the understanding of the structure,
function, and evolution of genomes in all kingdoms of life and the application of genome sciences and technologies to challenging problems
in biology and medicine. The scope of the journal is broad and we welcome original, full-length, and timely papers in all of the following
areas:
• Comparative genomics analysis that yields valuable insights into conserved and divergent aspects of function, regulation,
and evolution
• Bioinformatics and computational biology with particular emphasis on data mining and improvements in data annotation
and integration
• Functional genomics approaches involving the use of large-scale and/or high-throughput methods to understand
genome-scale function and regulation of transcriptomes and proteomes
• Identification of genes involved in disease and complex
traits, including responses to drugs and other xenobiotics
• Significant advances in genetic and genomics technologies and their
applications, including chemical genomics
In addition to full-length papers,
Genomics accepts a number of different article
types.
As a result of
Genomics' strict quality measures, the journal rejects as much of 70 % of all submissions received.
Each manuscript should be accompanied by a Cover letter outlining the basic findings of the manuscript and their significance.
Please submit, with the manuscript, the names and addresses of five potential referees.
Full length articles
Organization should be Abstract, Introduction, Results, Discussion, Materials and methods, Acknowledgments,
and References. There is a limit of 8 display items (figures plus tables) and 50 references. Manuscripts should be no more than 8
published
pages. Accepted papers that are over 8 pages may be returned to the authors for additional editing. Manuscript length can be estimated
by the total number of characters (spaces included), not the number of typed pages. The average number of characters per published page
is approximately 7000. Count each table or figure as 2450 characters and add to the character count of your manuscript text. In other
words, a regular submission should have no more than 56,000 characters (that is, 8 published pages).
Readers are invited to submit
ideas and proposals for reviews and minireviews; they should not submit complete or finished manuscripts prior to consultation with the
editor-in-chief or one of the associate editors.
Minireviews
The journal encourages the submission of concise, highly
focused review articles summarizing recent progress in very active areas of research involving the analysis of genomes. Authors wishing
to prepare such reviews should submit a short proposal, including an expected date of submission, to the editor.
Special features.
In addition to minireviews, special reviews of research programs for mapping and sequencing, historical sketches, genomics news, etc.,
are published periodically.
Short communications are not encouraged.
Single-gene reports will not be considered unless they are
accompanied by significant or novel insights into their structure, evolution, and/or expression. With respect to single genes, functional
assertions should be supported by experimental evidence; e.g., functional inferences based solely on routine analysis of homology are
insufficient. Authors are encouraged to identify and report any discrepancies between their findings and annotations in the major genome
databases.
Manuscripts that do not meet the general criteria or standards for publication in
Genomics will be immediately
returned to the authors, without detailed review.
Contact details for submission
Articles for Genomics should be submitted via the journal's online submission and editorial system at
http://ees.elsevier.com/geno.
Customer support is available 24/7:
Please use our help site at:
http://epsupport.elsevier.com/. Here you will be able
to learn more about the online submission and editorial system via interactive tutorials, explore a range of problem solutions via our
knowledgebase, and find answers to frequently asked questions. You will also find our 24/7 support contact details should you need any
assistance from one of our customer service representatives.
For questions on the submission and reviewing process, please contact
the Editorial Office at
genomics@elsevier.com.
Page charges
This journal has no page charges.
Ethics in publishing
For information on Ethics in publishing and Ethical guidelines for journal publication
see
http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Animal Experimentation
Circumstances relating to animal experimentation must meet the International Guiding
Principles for Biomedical Research Involving Animals as issued by the Council for the International Organizations of Medical Sciences.
They are obtainable from: Executive Secretary C.I.O.M.S., c/o WHO, Via Appia, CH-1211 Geneva 27, Switzerland, or at the following URL:
http://www.cioms.ch/frame_1985_texts_of_guidelines.htm
Authors may also wish to refer to the ethical guidelines published
on the website of the International Society for Applied Ethology
http://www.applied-ethology.org/ethicalguidelines.htm,
or read the following article: Sherwin, C.M., Christiansen, S.B., Duncan, I.J., Erhard, H., Lay, D., Mench, J., O'Connor, C., and Petherick,
C. (2003), 'Guidelines for the ethical use of animals in applied animal behaviour research', Applied Animal Behaviour Science, 81: 291-305.
Unnecessary cruelty in animal experimentation is not acceptable.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other
relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence,
or be perceived to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously
(except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any
other language, without the written consent of the copyright-holder.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before
the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names,
must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name
should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they
agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the
author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the
corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors
of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After
the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published
in an online issue will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more
information on this and copyright see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest
possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together
with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of
contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher
is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations
(please consult
http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s)
must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use
by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred
to:
http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article
and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data;
in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement
then this should be stated. Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose
articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
Open access
This journal offers you the option of making your article freely available to all via the ScienceDirect
platform. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been
accepted for publication. The fee of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions
and funding bodies have entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements
are available at
http://www.elsevier.com/fundingbodies. Authors of accepted articles, who wish to take advantage of this
option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf). Whatever
access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article
on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://webshop.elsevier.com/languageservices
or our customer support site at
http://support.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally
online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files
to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are
converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All
correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for
a paper trail.
Referees
Please submit, with the manuscript, the names,
addresses and e-mail addresses of three potential referees. Note that the editor retains the sole right to decide whether or not the
suggested reviewers are used.
Additional Information
Sharing information
and materials
It is expected that all new biological or other reagents described in papers published in
Genomics will
be made available freely to all qualified members of the scientific community upon written request. If delays in strain or vector distribution
are anticipated, or if these are available from sources other than the author(s), this must be indicated and, if the editor thinks it
necessary, explained.
Submission of data to databases
The editorial policy of
Genomics is to require the use
of databases. Deposit of data in the appropriate database(s) is a condition of publication. New nucleotide data must be submitted and
deposited in the DDBJ/EMBL/GenBank databases and an accession number obtained before the paper can be accepted for publication. Submission
to any one of the three collaborating databanks is sufficient to ensure data entry in all.
The accession number should be included
in the manuscript as a footnote on the title page: "Sequence data from this article have been deposited with the DDBJ/EMBL/GenBank
Data Libraries under Accession No. ...." If requested, the database will withhold release of data until publication. The most convenient
method for submitting sequence data is by the World Wide Web:
DDBJ via SAKURA,
http://sakura.ddbj.nig.ac.jp/
EMBL via WEBIN,
http://www.ebi.ac.uk/embl/Submission/webin.html
GenBank via BankIt,
http://www.ncbi.nlm.nih.gov/BankIt/
Stand-alone submission tool Sequin,
http://www.ncbi.nlm.nih.gov/Sequin/
Mouse Genome Informatics,
http://www.informatics.jax.org/mgihome/
For special types of submissions (for example, genomes, bulk submissions), additional submission protocols are available from the
above sites. Database contact information:
DDBJ:
Center for Information Biology and DNA Data Bank of Japan
National Institute
of Genetics
1111 Yata
Mishima, Shizuoka 411-8540, Japan
Telephone: 81 55981 6853; Fax: 81 55981 6849
E-mail:
ddbj@ddbj.nig.ac.jp
Web URL:
http://www.ddbj.nig.ac.jp/
EMBL
EMBL Nucleotide Sequence Submissions
European Bioinformatics
Institute
Wellcome Trust Genome Campus
Hinxton, Cambridge CB10 1SD, UK
Telephone: 44 1223 494499; Fax: 44 1223 494472
E-mail:
datasubs@ebi.ac.uk
Web URL:
http://www.ebi.ac.uk
GenBank
National Center for Biotechnology
Information
National Library of Medicine
Building 38A, Room 8N-802
Bethesda, MD 20894, USA
Telephone: (301) 496-2475;
Fax: (301) 480-9241
E-mail:
info@ncbi.nlm.nih.gov Web URL:
http://www.ncbi.nlm.nih.gov
Use of wordprocessing software
It
is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep
the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular,
do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts
etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If
no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional
manuscripts (see also the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication). Note that source
files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on
Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of
your wordprocessor.
Article structure
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should
be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for
internal cross-referencing: do not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear
on its own separate line.
Introduction
State the objectives of the
work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already
published should be indicated by a reference: only relevant modifications should be described.
Theory/calculation
A Theory section should extend, not repeat, the background to the article already dealt with in
the Introduction and lay the foundation for further work. In contrast, a Calculation section represents a practical development from
a theoretical basis.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined
Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which
may stand alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for
tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
•
Title.
Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations
and formulae where possible.
•
Author names and affiliations.
Where the family name may be ambiguous (e.g., a
double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names.
Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address.
Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at all stages of refereeing and publication, also
post-publication.
Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address
and the complete postal address. Contact details must be kept up to date by the corresponding author.
•
Present/permanent
address.
If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address'
(or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work
must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is required. The abstract should state briefly the purpose of the
research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able
to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard
or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding
general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly
established in the field may be eligible. These keywords will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of
the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the
footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include
them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g.,
providing language help, writing assistance or proof reading the article, etc.).
Nomenclature
and Units
Authors must use approved nomenclature for all genes, and all manuscripts will undergo a nomenclature check prior
to publication. All unapproved symbols must be replaced with approved symbols (throughout the text and figures). To avoid delays to your
manuscript please obtain approval for any new gene symbols prior to submitting your manuscript. Copies of emails documenting the approval
of any new symbols should accompany all submissions. Approved human gene symbols may be obtained before submission from the HUGO Gene
Nomenclature Committee (HGNC: contact Dr Elspeth Bruford, EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton,
Cambridgeshire CB10 1SD, UK); e-mail:
hgnc@genenames.org;
http://www.genenames.org/. Approved mouse nomenclature
may be obtained before submission from L. J. Maltais, The Jackson Laboratory, Bar Harbor, ME 04609-0800, USA; telephone: (207) 288-6429;
fax: (207) 288-6132; e-mail:
ljm@informatics.jax.org;
http://www.informatics.jax.org/nomen/. In mouse, mutant
strains and transgenic alleles also require approved symbols; see
http://www.informatics.jax.org/.
Use of unapproved
gene symbols will likely delay publication.
Human and mouse protein symbols should be denoted in all capital letters (for example,
FGF8). Use of "h" and "m" prefixes to distinguish between human and mouse proteins is not permitted. Instead, "mouse" or "human"
should be inserted before the relevant protein symbol in cases where it is necessary to distinguish between human and mouse proteins.
(This protocol extends to proteins of all other organisms.)
Authors must use SI units and follow the guidelines for abbreviations
and symbols of the IUPAC-IUBMB Joint Commission on Biochemical Nomenclature (
http://www.chem.qmw.ac.uk/iupac/jcbn/).
Database linking and Accession numbers
Elsevier aims at connecting online articles with external databases
which are useful in their respective research communities. If your article contains relevant unique identifiers or accession numbers
(bioinformatics) linking to information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases, then
please indicate those entities according to the standard explained below.
Authors should explicitly mention the
database abbreviation
(as mentioned below) together with the actual database number, bearing in mind that an error in a letter or number can result in
a dead link in the online version of the article.
Please use the following format:
Database ID: xxxx
Links can be provided
in your online article to the following databases (examples of citations are given in parentheses):
•
GenBank:
Genetic sequence database at the National Center for Biotechnical Information (NCBI) (GenBank ID: BA123456)
•
PDB:
Worldwide Protein Data Bank (PDB ID: 1TUP)
•
CCDC: Cambridge Crystallographic
Data Centre (CCDC ID: AI631510)
•
TAIR: The Arabidopsis Information
Resource database (TAIR ID: AT1G01020)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
MINT: Molecular INTeractions
database (MINT ID: 6166710)
•
MI: EMBL-EBI OLS Molecular
Interaction Ontology (MI ID: 0218)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
GenBank
DNA sequences and GenBank
accession numbers. Authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these
sources should type this information in the following manner: For each and every accession number cited in an article, authors should
type the accession number in bold, underlined text. Letters in the accession number should always be capitalized (see example below).
This combination of letters and format will enable the typesetter to recognize the relevant texts as accession numbers and add the required
link to GenBank sequences.
Example: GenBank accession nos.
AI631510 , AI631511 , AI632198 , and
BF223228 ), a
B-cell tumor from a chronic lymphatic leukemia (GenBank accession no.
BE675048 ), and a T-cell lymphoma (GenBank accession no.
AA361117 ).
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result
in a dead link. In the final version of the
printed article, the accession number text will not appear bold or underlined.
In the final version of the
electronic copy, the accession number text will be linked to the appropriate source in the NCBI
databases, enabling readers to go directly to that source from the article.
Math
formulae
Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal
line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently
denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the
text).
Footnotes
Footnotes should be used sparingly. Number them consecutively
throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be
used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at
the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate each footnote in a
table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing
of your original artwork.
• Save text in illustrations as 'graphics' or enclose the font.
• Only use the following
fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
•
Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide
on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged
to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application
used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save
the text as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line
drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please
do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
•
Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office
files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure,
at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether
or not these illustrations are reproduced in color in the printed version.
For color reproduction in print, you will receive information
regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or
on the Web only. For further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by converting color figures to 'gray scale' (for the printed version
should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached
to the figure. A caption should comprise a brief title (
not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the
table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that
the data presented in tables do not duplicate results described elsewhere in the article.
References
Citation in text
Please ensure that every reference
cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full.
Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the journal and should include a substitution
of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies
that the item has been accepted for publication.
Web references
As
a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author
names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the
reference list) under a different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and
any citations in the text) to other articles in the same Special Issue.
Reference
management software
This journal has standard templates available in key reference management packages EndNote (
http://www.endnote.com/support/enstyles.asp)
and Reference Manager (
http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only
need to select the appropriate journal template when preparing their article and the list of references and citations to these will be
formatted according to the journal style which is described below.
Reference style
Text: Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to,
but the reference number(s) must always be given.
Example: '..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different
result ....'
List: Number the references (numbers in square brackets) in the list in the order in which they appear in the
text.
Examples:
Reference to a journal publication:
[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, The art of
writing a scientific article, J. Sci. Commun. 163 (2010) 51–59.
Reference to a book:
[2] W. Strunk Jr., E.B. White, The
Elements of Style, fourth ed., Longman, New York, 2000.
Reference to a chapter in an edited book:
[3] G.R. Mettam, L.B. Adams,
How to prepare an electronic version of your article, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing
Inc., New York, 2009, pp. 281–304.
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Video data
Elsevier accepts
video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that
they wish to submit with their article are strongly encouraged to include these within the body of the article. This can be done in the
same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All
submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video
or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum size
of 50 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products,
including ScienceDirect:
http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame
from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your
video data. For more detailed instructions please visit our video instruction pages at
http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and
the print version for the portions of the article that refer to this content.
Supplementary
data
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files
offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips
and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products,
including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable,
please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with
the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction
pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please
consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author
has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
•
Telephone and fax numbers
All necessary files have been uploaded, and contain:
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been 'spell-checked'
and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference
list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources
(including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge)
and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the
Web is required, black-and-white versions of the figures are also supplied for printing purposes
For any further information please
visit our customer support site at
http://support.elsevier.com.
Additional Information
Cover art. Authors submitting a manuscript
for consideration may also submit color figures for exclusive use as cover illustrations. These figures do not need to relate to the
manuscript being submitted, but should relate to the larger scope and focus of
Genomics. Submit art in electronic form (TIFF
and EPS files only). A short (one-line) legend should accompany each figure.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI)
may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to
a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium
for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The
correct format for citing a DOI is shown as follows (example taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to create URL hyperlinks to documents on the web, the DOIs are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe
Reader version 7 (or higher) available free from
http://get.adobe.com/reader. Instructions on how to annotate PDF files
will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark
the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the
pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text,
tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately – please let us have all your
corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully
before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that
Elsevier may proceed with the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra
charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF
file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining
the terms and conditions of use.
Additional Information
US National
Institutes of Health (NIH) voluntary posting (" Public Access") policy
Elsevier facilitates author response to the NIH voluntary
posting request (referred to as the NIH "Public Access Policy"; see
http://www.nih.gov/about/publicaccess/index.htm)
by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication.
Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at
NIHauthorrequest@elsevier.com)
that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to
facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that
will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully
to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is
prohibited.
For inquiries relating to the submission
of articles (including electronic submission) please visit this journal's homepage. Contact details for questions arising after acceptance
of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles at
http://www.elsevier.com/trackarticle.
You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ) and/or contact Customer Support via
http://support.elsevier.com.
